ADAPTIVE OPTICAL METASURFACES FOR REAL-TIME, LABEL-FREE AND NON-DESTRUCTIVE 7D DIGITAL PATHOLOGY

OPTIPATH aims to revolutionize tissue diagnosis by providing real-time, non-destructive 3D imaging using advanced optical technologies and machine learning to enhance accuracy and reduce variability.

Subsidie
€ 3.276.577
2025

Projectdetails

Introduction

Treatment decisions for many pathological conditions, including inflammatory, degenerative, autoimmune, infectious diseases, and cancer, are largely based on microscopy study of the surgically excised tissue specimens (histology).

Overview of OPTIPATH

OPTIPATH provides a new paradigm for gathering objective optical tissue-dependent data, which is essential to overcoming the diagnostic challenges of inter-observer variability and limited sensitivity and specificity.

Features of OPTIPATH

OPTIPATH will offer non-destructive, label-free, real-time, 3D-presentation of tissue samples. This is enabled by:

  1. Revolutionary nano-photonic optical metasurfaces (OMS) for simultaneous single-shot acquisition of spectral and polarimetric information.
  2. Adaptive OMS actuated by thin-film piezoelectric Micro-Electro-Mechanical-Systems (MEMS) for rapid Vector Vortex Beam (VVB) shaping of light.
  3. Rapid confocal 3D imaging.

Data Interpretation

The wealth of objective diagnostic data provided will be interpreted using Machine Learning (ML) / Deep Learning (DL), which is essential to overcome inter-observer variability in diagnosis and provide actionable insights to the clinician.

Benefits of OPTIPATH

By utilizing optical markers present in unprepared tissue, histological procedures can be dramatically sped up, offering real-time diagnosis in operation theatres and pathology departments.

Conclusion

By offering timely and accurate diagnosis, OPTIPATH will enable early diagnosis and improved prognosis of recovery.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 3.276.577
Totale projectbegroting€ 3.276.577

Tijdlijn

Startdatum1-2-2025
Einddatum31-1-2028
Subsidiejaar2025

Partners & Locaties

Projectpartners

  • SINTEF ASpenvoerder
  • SYDDANSK UNIVERSITET
  • OULUN YLIOPISTO
  • ASTON UNIVERSITY
  • NIL TECHNOLOGY APS
  • UNIVERSITETET I OSLO
  • OSLO UNIVERSITETSSYKEHUS HF

Land(en)

NorwayDenmarkFinlandUnited Kingdom

Vergelijkbare projecten binnen EIC Pathfinder

EIC Pathfinder

"Creation of innovative ""humidity to electricity"" renewable energy conversion technology towards sustainable energy challenge"

The CATCHER project aims to develop scalable technology for converting atmospheric humidity into renewable electricity, enhancing EU leadership in clean energy innovation.

€ 2.996.550
EIC Pathfinder

Quantitative Ultrasound Stochastic Tomography - Revolutionizing breast cancer diagnosis and screening with supercomputing-based radiation-free imaging.

The project aims to revolutionize breast cancer imaging by developing adjoint-based algorithms for uncertainty quantification, enhancing diagnostic confidence through high-resolution, radiation-free images.

€ 2.744.300
EIC Pathfinder

Dynamic Spatio-Temporal Modulation of Light by Phononic Architectures

Dynamo aims to revolutionize imaging technologies by enabling simultaneous light modulation at GHz rates, enhancing processing speed and positioning Europe as a leader in optical advancements.

€ 2.552.277
EIC Pathfinder

Emerging technologies for crystal-based gamma-ray light sources

TECHNO-CLS aims to develop novel gamma-ray light sources using oriented crystals and high-energy particle beams, enhancing applications in various scientific fields through innovative technology.

€ 2.643.187

Vergelijkbare projecten uit andere regelingen

EIC Transition

Chemometric histopathology via coherent Raman imaging for precision medicine

The CHARM project aims to revolutionize cancer diagnosis with a novel AI-integrated, label-free tissue analysis system, achieving high accuracy in tumor identification and classification.

€ 2.441.979
ERC POC

Optical imaging platform for high-throughput longitudinal studies of the eye in disease models

The OPTIMEYEZ project aims to enhance a novel multi-contrast optical imaging platform for non-invasive retinal studies, facilitating drug development in neurological diseases while reducing animal use.

€ 150.000
ERC ADG

In vivo Immunofluorescence-Optical Coherence Tomography

Develop a high-resolution endoscopic imaging system combining Optical Coherence Tomography and fluorescent antibodies for improved diagnosis and treatment of esophageal cancer and lung disease.

€ 2.500.000
EIC Transition

Enabling the transition to 3D digital pathology

3DPATH aims to develop a clinically viable 3D tissue scanner using advanced light-sheet fluorescence microscopy to enhance histopathology accuracy and improve patient care globally.

€ 2.493.683